Archive for January, 2008

Patent Expert Takes on Proposed Legislation in National Newspaper (Centre Daily Times)

Posted in Patents on January 29th, 2008

Patent Expert Takes on Proposed Legislation in National Newspaper (Centre Daily Times)
Alexander Poltorak, chairman and CEO of General Patent Corporation, condemned patent legislation being considered by the Senate in an opinion essay published yesterday in The Christian Science Monitor. The article can be viewed online at http://www.csmonitor.com/2008/0128/p09s02-coop.html?page=1.

DTL Licenses Key Cell Phone Patent to Samsung (Business Wire via Yahoo!7 Finance)

Posted in Patents on January 28th, 2008

DTL Licenses Key Cell Phone Patent to Samsung (Business Wire via Yahoo!7 Finance)
General Patent Corporation International (GPCI), a leading patent licensing and enforcement firm, announced today on behalf of its client, Digital Technology Licensing LLC (DTL), that it has licensed a key cell phone patent to Samsung Electronics Co., LTD.

U.S. Patent Office Rejects Patents On Gilead’s Antiretroviral Viread (Medical News Today)

Posted in Patents on January 26th, 2008

U.S. Patent Office Rejects Patents On Gilead’s Antiretroviral Viread (Medical News Today)
The U.S. Patent and Trademark Office on Wednesday rejected four patents on Gilead Sciences’ antiretroviral drug Viread, Reuters reports. Viread is known generically as tenofovir and is sold as part of Gilead’s combination therapies Truvada and Atripla.

Whirlpool, LG Elec in patent row over refrigerators (Reuters via Yahoo! Malaysia News)

Posted in Patents on January 23rd, 2008

Whirlpool, LG Elec in patent row over refrigerators (Reuters via Yahoo! Malaysia News)
SEOUL, Jan 24 – Whirlpool Corp , the world’s top appliance maker, filed a patent infringement suit against LG Electronics Inc’s refrigerators sold in the United States as the two battle for the premium U.S. appliance market.

Vapotherm(R) Announces Validation of U.S. Patent (PR Newswire via Yahoo! News)

Posted in Patents on January 22nd, 2008

Vapotherm(R) Announces Validation of U.S. Patent (PR Newswire via Yahoo! News)
VAPOTHERM REINFORCES LEADERSHIP ROLE WITH PATENT FOR APPARATUS AND METHOD FOR RESPIRATORY TRACT THERAPY

Dr Reddy’s settles patent issue with Novartis (Business Standard India)

Posted in Patents on January 21st, 2008

Dr Reddy’s settles patent issue with Novartis (Business Standard India)
Dr Reddy’s Laboratories has settled a patent dispute in the US with the Switzerland-based drug maker Novartis Pharma over Exelon (rivastigmine tartrate), used in the treatment of a type of dementia of the Alzheimer’s type.

Payment Data System sells bill payment patent to PCT Software Data (Finextra)

Posted in Patents on January 20th, 2008

Payment Data System sells bill payment patent to PCT Software Data (Finextra)
Payment Data System, Inc. (OTCBB:PYDS) today announced that it has completed the sale of selected patents and patent applications to PCT Software …

Justices Skeptical of Patent-Holders’ Claim (Law.com via Yahoo! Finance)

Posted in Patents on January 17th, 2008

Justices Skeptical of Patent-Holders’ Claim (Law.com via Yahoo! Finance)
In a closely watched case that may determine how far companies can go when demanding fees for patents they’ve licensed, several Supreme Court justices Wednesday seemed open to limiting patent-holders’ rights in connection with the use of their products by downstream purchasers in the manufacturing process.

Medicis Key Drug Faces Patent Challenge (AP via Yahoo! Finance)

Posted in Patents on January 15th, 2008

Medicis Key Drug Faces Patent Challenge (AP via Yahoo! Finance)
Shares of Medicis Pharmaceutical Corp., which makes skin medications, fell sharply to a new annual low after Impax Laboratories challenged a patent for its Solodyn drug for the treatment of acne.

Forest Labs sues Indian cos for patent infringement (Express India)

Posted in Patents on January 12th, 2008

Forest Labs sues Indian cos for patent infringement (Express India)
US-based Forest Laboratories has sued leading Indian drug firms, Lupin Ltd, Orchid Chemicals & Pharmaceuticals Ltd and Wockhardt Ltd, for alleged infringement of Forest’s Alzheimer’s drug patent.